The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
HDL as a target in the treatment of atherosclerotic cardiovascular disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043 · cited 1×
“This global epidemic affects not only the industrialized nations, but also the developing worl”
BackgroundHelsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Clofibrate and Niacin in Coronary Heart Disease
(1975) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1975.03240160024021 · Cited by 1,747
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
Repa, J. J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J.-M. A., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., & Mangelsdorf, D. J. (2000) · Genes & Development · doi:10.1101/gad.844900 · Cited by 1,692
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J.-M. A., Hammer, R. E., & Mangelsdorf, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81432-4 · Cited by 1,436
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.-C., Deleuze, J.-F., Brewer, H. B., Duverger, N., Denèfle, P., et al. (1999) · Nature Genetics · doi:10.1038/11921 · Cited by 1,433
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Molecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146
Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol
Cohen, J. C., Kiss, R. S., Pertsemlidis, A., Marcel, Y. L., McPherson, R., & Hobbs, H. H. (2004) · Science · doi:10.1126/science.1099870 · Cited by 1,108
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Wang, N., Lan, D., Chen, W., Matsuura, F., & Tall, A. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403506101 · Cited by 1,061
Self-citationOliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., & Clift, S. M. (1991) · Nature · doi:10.1038/353265a0 · Cited by 986
Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X Receptor
Costet, P., Luo, Y., Wang, N., & Tall, A. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003337200 · Cited by 979
Self-citationSynthetic LXR ligand inhibits the development of atherosclerosis in mice
Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G., Goodman, J., Hagger, G. N., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112059299 · Cited by 947
Robins, S. J., Collins, D., Wittes, J. T., Papademetriou, V., Deedwania, P. C., Schaefer, E. J., McNamara, J. R., Kashyap, M. L., Hershman, J. M., Wexler, L. F., et al. (2001) · JAMA · doi:10.1001/jama.285.12.1585 · Cited by 921
Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men
Rhoads, G. G., Gulbrandsen, C. L., & Kagan, A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602052940601 · Cited by 878
Assmann, G., & Schulte, H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90550-i · Cited by 872
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 861
Self-citationGardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 1×
“This change in lipoprotein subclass size can be considered to be favourable because earlier studies have found low levels of large HDL and high levels of small, dense LDL associated with coronary heart diseas”
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
Cockerill, G. W., Rye, K.-A., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 783
Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774
Williams, C. L., Hayman, L. L., Daniels, S. R., Robinson, T. N., Steinberger, J., Paridon, S., & Bazzarre, T. (2002) · Circulation · doi:10.1161/01.cir.0000019555.61092.9e · Cited by 774
Yuhanna, I. S., Zhu, Y., Cox, B. E., Hahner, L. D., Osborne-Lawrence, S., Lu, P., Marcel, Y. L., Anderson, R. G. W., Mendelsohn, M. E., Hobbs, H. H., et al. (2001) · Nature Medicine · doi:10.1038/89986 · Cited by 742
Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
Kozarsky, K. F., Donahee, M. H., Rigotti, A., Iqbal, S. N., Edelman, E. R., & Krieger, M. (1997) · Nature · doi:10.1038/387414a0 · Cited by 699
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
Nofer, J.-R., van der Giet, M., Tölle, M., Wolinska, I., von Wnuck Lipinski, K., Baba, H. A., Tietge, U. J., Gödecke, A., Ishii, I., Kleuser, B., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18004 · Cited by 698
Carlson, L. A., & ROSENHAMER, G. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb15891.x · Cited by 677
Peters, J. M., Lee, S. S. T., Li, W., Ward, J. M., Gavrilova, O., Everett, C., Reitman, M. L., Hudson, L. D., & Gonzalez, F. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5119-5128.2000 · Cited by 633
HDL and arteriosclerosis: beyond reverse cholesterol transport
Nofer, J.-R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., & Eckardstein, A. V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 595
Barak, Y., Liao, D., He, W., Ong, E. S., Nelson, M. C., Olefsky, J. M., Boland, R., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012610299 · Cited by 586
Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J. W., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18730 · Cited by 573
Plump, A. S., Scott, C. J., & Breslow, J. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9607 · Cited by 568
Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid
Wise, A., Foord, S. M., Fraser, N. J., Barnes, A. A., Elshourbagy, N., Eilert, M., Ignar, D. M., Murdock, P. R., Steplewski, K., Green, A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210695200 · Cited by 539
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K., & Shinkai, H. (2000) · Nature · doi:10.1038/35018119 · Cited by 531
Lipoproteins, Cardiovascular Disease, and Death: The Framingham Study
Gordon, T. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090024008 · Cited by 526
Llodrá, J., Angeli, V., Liu, J., Trogan, E., Fisher, E. A., & Randolph, G. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403259101 · Cited by 509
Pasceri, V., Wu, H. D., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.101.3.235 · Cited by 504
Brown, M. L., Inazu, A., Hesler, C. B., Agellon, L. B., Mann, C., Whitlock, M. E., Marcel, Y. L., Milne, R. W., Koizumi, J., Mabuchi, H., et al. (1989) · Nature · doi:10.1038/342448a0 · Cited by 467
Self-citationde Grooth, G. J., Kuivenhoven, J. A., Stalenhoef, A. F. H., de Graaf, J., Zwinderman, A. H., Posma, J. L., van Tol, A., & Kastelein, J. J. P. (2002) · Circulation · doi:10.1161/01.cir.0000015857.31889.7b · Cited by 456
Identification of macrophage liver X receptors as inhibitors of atherosclerosis
Tangirala, R. K., Bischoff, E. D., Joseph, S. B., Wagner, B. L., Walczak, R., Laffitte, B. A., Daige, C. L., Thomas, D., Heyman, R. A., Mangelsdorf, D. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182199799 · Cited by 438
Collins, J. L., Fivush, A. M., Watson, M. A., Galardi, C. M., Lewis, M. C., Moore, L. B., Parks, D. J., Wilson, J. G., Tippin, T. K., Binz, J. G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255116 · Cited by 434
A novel endothelial-derived lipase that modulates HDL metabolism
Jaye, M., Lynch, K. J., Krawiec, J., Marchadier, D., Maugeais, C., Doan, K., South, V., Amin, D., Perrone, M., & Rader, D. J. (1999) · Nature Genetics · doi:10.1038/7766 · Cited by 427
Navab, M., Anantharamaiah, G. M., Hama, S., Garber, D. W., Chaddha, M., Hough, G., Lallone, R., & Fogelman, A. M. (2002) · Circulation · doi:10.1161/hc0302.103711 · Cited by 401
Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages
Aiello, R. J., Brees, D., Bourassa, P.-A., Royer, L., Lindsey, S., Coskran, T., Haghpassand, M., & Francone, O. L. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000014804.35824.da · Cited by 390
A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR
Downes, M., Verdecia, M. A., Roecker, A. J., Hughes, R., Hogenesch, J. B., Kast-Woelbern, H. R., Bowman, M. E., Ferrer, J.-L., Anisfeld, A. M., Edwards, P. A., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00104-7 · Cited by 390
Frick, M. H., Syvänne, M., Nieminen, M. S., Kauma, H., Majahalme, S., Virtanen, V., Kesäniemi, Y. A., Pasternack, A., & Taskinen, M.-R. (1997) · Circulation · doi:10.1161/01.cir.96.7.2137 · Cited by 388
Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
Pászty, C., Maeda, N., Verstuyft, J., & Rubin, E. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117412 · Cited by 374
Akiyama, T. E., Sakai, S., Lambert, G., Nicol, C. J., Matsusue, K., Pimprale, S., Lee, Y.-H., Ricote, M., Glass, C. K., Brewer, H. B., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2607-2619.2002 · Cited by 368
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice
Alberti, S., Schuster, G., Parini, P., Feltkamp, D., Diczfalusy, U., Rudling, M., Angelin, B., Björkhem, I., Pettersson, S., & Gustafsson, J.-′. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9794 · Cited by 367
The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance
Vicent, D., Ilany, J., Kondo, T., Naruse, K., Fisher, S. J., Kisanuki, Y. Y., Bursell, S., Yanagisawa, M., King, G. L., & Kahn, C. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15211 · Cited by 356
Bonow, R. O., Smaha, L. A., Smith, S. C., Mensah, G. A., & Lenfant, C. (2002) · Circulation · doi:10.1161/01.cir.0000035036.22612.2b · Cited by 353
Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues
Van Eck, M., Bos, I. S. T., Kaminski, W. E., Orsó, E., Rothe, G., Twisk, J., Böttcher, A., Van Amersfoort, E. S., Christiansen-Weber, T. A., Fung-Leung, W.-P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092327399 · Cited by 348
Rittershaus, C. W., Miller, D. P., Thomas, L. J., Picard, M. D., Honan, C. M., Emmett, C. D., Pettey, C. L., Adari, H., Hammond, R. A., Beattie, D. T., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2106 · Cited by 312
Uittenbogaard, A., Shaul, P. W., Yuhanna, I. S., Blair, A., & Smart, E. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11278 · Cited by 310
Vu-Dac, N., Chopin-Delannoy, S., Gervois, P., Bonnelye, E., Martin, G., Fruchart, J.-C., Laudet, V., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25713 · Cited by 297
Claudel, T., Leibowitz, M. D., Fiévet, C., Tailleux, A., Wagner, B., Repa, J. J., Torpier, G., Lobaccaro, J.-M., Paterniti, J. R., Mangelsdorf, D. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041609298 · Cited by 292
Characterization of the lipolytic activity of endothelial lipase
McCoy, M. G., Sun, G.-S., Marchadier, D., Maugeais, C., Glick, J. M., & Rader, D. J. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30466-1 · Cited by 280
Wang, N., Chen, W., Linsel-Nitschke, P., Martinez, L. O., Agerholm-Larsen, B., Silver, D. L., & Tall, A. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16808 · Cited by 277
Self-citationInfluence of nicotinic acid on metabolism of cholesterol and triglycerides in man
Grundy, S. M., Mok, H. Y., Zech, L., & Berman, M. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34737-4 · Cited by 270
The Peroxisome Proliferator-activated Receptor δ Promotes Lipid Accumulation in Human Macrophages
Vosper, H., Patel, L., Graham, T. L., Khoudoli, G. A., Hill, A., Macphee, C. H., Pinto, I., Smith, S. A., Suckling, K. E., Wolf, C. R., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108482200 · Cited by 268
Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels
Haghpassand, M., Bourassa, P.-A. K., Francone, O. L., & Aiello, R. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12810 · Cited by 256
Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population
Frikke-Schmidt, R., Nordestgaard, B. G., Jensen, G. B., & Tybjærg-Hansen, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420361 · Cited by 250
Berthou, L., Duverger, N., Emmanuel, F., Langouët, S., Auwerx, J., Guillouzo, A., Fruchart, J. C., Rubin, E., Denèfle, P., Staels, B., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118687 · Cited by 248
Inazu, A., Jiang, X. C., Haraki, T., Yagi, K., Kamon, N., Koizumi, J., Mabuchi, H., Takeda, R., Takata, K., & Moriyama, Y. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117537 · Cited by 247
Prevalence of risk factors in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90924-a · Cited by 243
Expression and activation of the farnesoid X receptor in the vasculature
Bishop-Bailey, D., Walsh, D. T., & Warner, T. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400046101 · Cited by 242
Schaefer, E. J., Heaton, W. H., Wetzel, M. G., & Brewer, H. B. (1982) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.2.1.16 · Cited by 229
Eriksson, M., Carlson, L. A., Miettinen, T. A., & Angelin, B. (1999) · Circulation · doi:10.1161/01.cir.100.6.594 · Cited by 228
Curb, J. D., Abbott, R. D., Rodriguez, B. L., Masaki, K., Chen, R., Sharp, D. S., & Tall, A. R. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300520-jlr200 · Cited by 228
Self-citationDuverger, N., Kruth, H., Emmanuel, F., Caillaud, J.-M., Viglietta, C., Castro, G., Tailleux, A., Fievet, C., Fruchart, J. C., Houdebine, L. M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.4.713 · Cited by 225
Increased CD36 protein as a response to defective insulin signaling in macrophages
Liang, C.-P., Han, S., Okamoto, H., Carnemolla, R., Tabas, I., Accili, D., & Tall, A. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19528 · Cited by 225
Self-citationKimura, T., Sato, K., Malchinkhuu, E., Tomura, H., Tamama, K., Kuwabara, A., Murakami, M., & Okajima, F. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000079011.67194.5a · Cited by 223
Characterization of the Human ABCG1 Gene
Kennedy, M. A., Venkateswaran, A., Tarr, P. T., Xenarios, I., Kudoh, J., Shimizu, N., & Edwards, P. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105863200 · Cited by 217
Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo
Jin, W., Millar, J. S., Broedl, U., Glick, J. M., & Rader, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16146 · Cited by 217
Prevalence of Risk Factors in Men With Premature Coronary Artery Disease
Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J. (1992) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199203010-00011 · Cited by 217
Zhang, W., Yancey, P. G., Su, Y. R., Babaev, V. R., Zhang, Y., Fazio, S., & Linton, M. F. (2003) · Circulation · doi:10.1161/01.cir.0000093189.97429.9d · Cited by 207
Wang, N., Wang, W., Breslow, J. L., & Tall, A. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21001 · Cited by 205
Self-citationWaters, D. D., Guyton, J. R., Herrington, D. M., McGowan, M. P., Wenger, N. K., & Shear, C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.031 · Cited by 201
Arakawa, R., & Yokoyama, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202996200 · Cited by 200
Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., Terano, T., Sakai, M., Hakamata, H., Sakamoto, Y.-I., Naito, M., et al. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1882 · Cited by 191
Miao, B., Zondlo, S., Gibbs, S., Cromley, D., Hosagrahara, V. P., Kirchgessner, T. G., Billheimer, J., & Mukherjee, R. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300450-jlr200 · Cited by 186
Rubic, T., Trottmann, M., & Lorenz, R. L. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.014 · Cited by 182
Nuclear receptor regulation of cholesterol and bile acid metabolism
Repa, J. J., & Mangelsdorf, D. J. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00031-2 · Cited by 180
Identification of a subtype selective human PPARα agonist through parallel-array synthesis
Brown, P. J., Stuart, L. W., Hurley, K. P., Lewis, M. C., Winegar, D. A., Wilson, J. G., Wilkison, W. O., Ittoop, O. R., & Willson, T. M. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00188-3 · Cited by 177
Van Lenten, B. J., Wagner, A. C., Anantharamaiah, G. M., Garber, D. W., Fishbein, M. C., Adhikary, L., Nayak, D. P., Hama, S., Navab, M., & Fogelman, A. M. (2002) · Circulation · doi:10.1161/01.cir.0000030182.35880.3e · Cited by 173
Ueda, Y., Gong, E., Royer, L., Cooper, P. N., Francone, O. L., & Rubin, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000730200 · Cited by 166
The Role of High-Density Lipoproteins in Oxidation and Inflammation
Van Lenten, B. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00095-0 · Cited by 165
Cohen, J. C., Wang, Z., Grundy, S. M., Stoesz, M. R., & Guerra, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117603 · Cited by 162
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis
Garber, D. W., Datta, G., Chaddha, M., Palgunachari, M. N., Hama, S. Y., Navab, M., Fogelman, A. M., Segrest, J. P., & Anantharamaiah, G. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31163-9 · Cited by 157
Baker, P. W., Rye, K., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33375-7 · Cited by 154
Gong, M. C., Wilson, M. E., Kelly, T. H., Su, W., Dressman, J. L., Kincer, J. F., Matveev, S. V., Guo, L., Guerin, T. M., Li, X., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16777 · Cited by 152
Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models
Benoit, P., Emmanuel, F., Caillaud, J. M., Bassinet, L., Castro, G. R., Gallix, P., Fruchart, J., Branellec, D., Denèfle, P., & Duverger, N. (1999) · Circulation · doi:10.1161/01.cir.99.1.105 · Cited by 147
Ye, J., Iglesias, M. A., Watson, D. G., Ellis, B. A., Wood, L., Jensen, P. B., Sørensen, R. V., Larsen, P. J., Cooney, G. J., Wassermann, K., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00299.2002 · Cited by 146
Vrecer, M., Turk, S., Drinovec, J., & Mrhar, A. (2003) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp41567 · Cited by 143
Inhibition of Arterial Thrombus Formation by ApoA1 Milano
Li, D., Weng, S., Yang, B., Zander, D. S., Saldeen, T. G. P., Nichols, W. W., Khan, S. R., & Mehta, J. L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.378 · Cited by 143
Retinoic Acid Receptor-Mediated Induction of ABCA1 in Macrophages
Costet, P., Lalanne, F., Gerbod-Giannone, M. C., Molina, J. R., Fu, X., Lund, E. G., Gudas, L. J., & Tall, A. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7756-7766.2003 · Cited by 139
Self-citationLohray, B. B., Lohray, V. B., Bajji, A. C., Kalchar, S., Poondra, R. R., Padakanti, S., Chakrabarti, R., Vikramadithyan, R. K., Misra, P., Suresh, J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010143b · Cited by 137
Endothelial Lipase Modulates Susceptibility to Atherosclerosis in Apolipoprotein-E-deficient Mice
Ishida, T., Choi, S. Y., Kundu, R. K., Spin, J. M., Yamashita, T., Hirata, K., Kojima, Y., Yokoyama, M., Cooper, A. D., & Quertermous, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406360200 · Cited by 136
Spady, D. K., Kearney, D. M., & Hobbs, H. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33380-0 · Cited by 136
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis
Lund, E. G., Menke, J. G., & Sparrow, C. P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000056743.42348.59 · Cited by 135
Bielicki, J. K., & Oda, M. N. (2002) · Biochemistry · doi:10.1021/bi011716p · Cited by 132
The safety and immunogenicity of a CETP vaccine in healthy adults
Davidson, M. H., Maki, K. C., Umporowicz, D. M., Wheeler, A., Rittershaus, C. W., & Ryan, U. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00137-0 · Cited by 131
Li, X., Chyu, K., Faria‐Neto, J. R., Yano, J., Nathwani, N., Ferreira, C., Dimayuga, P. C., Cercek, B., Kaul, S., & Shah, P. K. (2004) · Circulation · doi:10.1161/01.cir.0000142857.79401.69 · Cited by 130
Sparrow, C. P., Baffic, J., Lam, M., Lund, E. G., Adams, A. D., Fu, X., Hayes, N. S., Jones, A. B., MacNaul, K. L., Ondeyka, J. G., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108225200 · Cited by 127
Fibrates Down-regulate Hepatic Scavenger Receptor Class B Type I Protein Expression in Mice
Mardones, P., Pilon, A., Bouly, M., Duran, D., Nishimoto, T., Arai, H., Kozarsky, K., Altayó, M., Miquel, J. F., Luc, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211627200 · Cited by 126
Granata, R., Trovato, L., Garbarino, G. M., Taliano, M., Ponti, R., Sala, G., Ghidoni, R., & Ghigo, E. (2004) · The FASEB Journal · doi:10.1096/fj.04-1618fje · Cited by 118
Lenten, B. J. V., Wagner, A. C., Navab, M., Anantharamaiah, G. M., Hui, E. K., Nayak, D. P., & Fogelman, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000147232.75456.b3 · Cited by 116
Larsen, P. J., Jensen, P. B., Sørensen, R. V., Larsen, L. K., Vrang, N., Wulff, E. M., & Wassermann, K. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2249 · Cited by 112
Willson, T. M., Jones, S. A., Moore, J. T., & Kliewer, S. A. (2001) · Medicinal Research Reviews · doi:10.1002/med.1023 · Cited by 110
Jiang, X., Masucci-Magoulas, L., Mar, J., Lin, M., Walsh, A., Breslow, J. L., & Tall, A. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74263-x · Cited by 108
Self-citationLiu, A. C., Lawn, R. M., Verstuyft, J. G., & Rubin, E. M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39932-6 · Cited by 107
Ng, D. S., Leiter, L. A., Vézina, C., Connelly, P. W., & Hegele, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116949 · Cited by 105
Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects
Saad, M. F., Greco, S. N., Osei, K., Lewin, A. J., Edwards, C., Nunez, M., Reinhardt, R. R., & for the Ragaglitazar Dose-Ranging Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1324 · Cited by 102
High-Density Lipoprotein Stimulates Myocardial Perfusion In Vivo
Levkau, B., Hermann, S., Theilmeier, G., van der Giet, M., Chun, J. J. M., Schober, O., & Schäfers, M. A. (2004) · Circulation · doi:10.1161/01.cir.0000147827.43912.ae · Cited by 100
Schaefer, E. J., McNamara, J. R., Tayler, T. D., Daly, J. A., Gleason, J. A., SEMAN, L. J., Ferrari, A., & Rubenstein, J. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02591-2 · Cited by 90
Niacin-Induced Hepatitis: A Potential Side Effect With Low-Dose Time-Release Niacin
Etchason, J., Miller, T. D., Squires, R. W., Allison, T. G., Gau, G. T., Marttila, J. K., & Kottke, B. A. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61171-9 · Cited by 90
Bruce, C., Beamer, L. J., & Tall, A. R. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80118-8 · Cited by 86
Self-citationExpression of the liver X receptor α and β in embryonic and adult mice
Annicotte, J., Schoonjans, K., & Auwerx, J. H. (2004) · The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · doi:10.1002/ar.a.20015 · Cited by 82
Chakrabarti, R., Vikramadithyan, R. K., Misra, P., Hiriyan, J., Raichur, S., Damarla, R. K. B., Gershome, C., Suresh, J., & Rajagopalan, R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705463 · Cited by 79
Thomas, J. S., Bramlett, K. S., Montrose, C., FOXWORTHY, P. S., Eacho, P. I., McCann, D., Cao, G., Kiefer, A. D., McCowan, J., Yu, K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209629200 · Cited by 71
Endothelial Lipase Promotes the Catabolism of ApoB-Containing Lipoproteins
Broedl, U. C., Maugeais, C., Millar, J. S., Jin, W., Moore, R. E., Fuki, I. V., Marchadier, D., Glick, J. M., & Rader, D. J. (2004) · Circulation Research · doi:10.1161/01.res.0000130657.00222.39 · Cited by 68
Assmann, G., & Schulte, H. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90152-4 · Cited by 64
Xu, Y., Mayhugh, D. R., Saeed, A., Wang, X., Thompson, R. C., Dominianni, S. J., Kauffman, R. F., Singh, J., Bean, J. S., Bensch, W. R., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034173l · Cited by 61
High-Density Lipoproteins as an Emerging Therapeutic Target for Atherosclerosis
Rader, D. J. (2003) · JAMA · doi:10.1001/jama.290.17.2322 · Cited by 60
Brand, C. L., Sturis, J., Gotfredsen, C. F., Fleckner, J., Fledelius, C., Hansen, B. F., Andersen, B., Ye, J., Sauerberg, P., & Wassermann, K. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00348.2002 · Cited by 60
Tan, J. H.-H., Low, P., Tan, Y.-S., Tong, M.-C., Saha, N., Yang, H., & Heng, C. (2003) · Human Genetics · doi:10.1007/s00439-003-0943-3 · Cited by 59
Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?
Moore, K. J., Fitzgerald, M. L., & Freeman, M. W. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200110000-00007 · Cited by 59
JSchaefer, E., HHeaton, W., GWetzel, M., et al. (1982) · Arteriosclerosis An Official Journal of the American Heart Association Inc · Cited by 59
Rinninger, F., Brundert, M., Jäckle, S., Galle, P. R., Busch, C., Izbicki, J. R., Rogiers, X., Henne‐Bruns, D., Kremer, B., Broelsch, C. E., et al. (1994) · Hepatology · doi:10.1002/hep.1840190507 · Cited by 53
Skrumsager, B. K., Nielsen, K. K., Müller, M., Pabst, G., Drake, P. G., & Edsberg, B. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257230 · Cited by 49
Niesor, E. J., Flach, J., Antoni, I., Perez, A., & Bentzen, C. L. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013398185 · Cited by 49
Miyachi, H., Nomura, M., Tanase, T., Takahashi, Y., Ide, T., Tsunoda, M., Murakami, K., & Awano, K. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00672-2 · Cited by 40
Kockx, M., Princen, H. M., & Kooistra, T. (1998) · PubMed · Cited by 38
Bruggen, D. V.-V., Kalkman, I., van Gent, T., van Tol, A., & Jansen, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32038 · Cited by 37
Kuwabara, K., Murakami, K., Todo, M., Aoki, T., Asaki, T., Murai, M., & Yano, J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064659 · Cited by 34
Kockx, M., Princen, H. M. G., & Kooistra, T. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615393 · Cited by 32
Thiol-bearing synthetic peptides retain the antioxidant activity of apolipoproteinA-IMilano
Jia, Z., Natarajan, P., Forte, T. M., & Bielicki, J. K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02143-5 · Cited by 22
Neele, D. M., Kaptein, A., Huisman, H., de Wit, E. C. M., & Princen, H. M. G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8279 · Cited by 13
Bavirti, S., Ghanaat, F., & Tayek, J. A. (2003) · Endocrine Practice · doi:10.4158/ep.9.6.487 · Cited by 13
Huang, Y., & Hall, I. H. (1996) · Archiv der Pharmazie · doi:10.1002/ardp.19963290702 · Cited by 3
Cited by
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Self-citationPopa, C., Netea, M. G., van Riel, P. L. C. M., van der Meer, J. W. M., & Stalenhoef, A. F. H. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r600021-jlr200 · Cited by 763
Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease
Barquera, S., Pedroza-Tobías, A., Medina, C., Hernández-Barrera, L., Bibbins-Domingo, K., Lozano, R., & Moran, A. E. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.06.006 · Cited by 709
SIRT1 Deacetylates and Positively Regulates the Nuclear Receptor LXR
Li, X., Zhang, S., Blander, G., Tse, J. G., Krieger, M., & Guarente, L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.032 · Cited by 634
Cholesterol Sensing, Trafficking, and Esterification
Chang, T.-Y., Chang, C. C. Y., Ohgami, N., & Yamauchi, Y. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104656 · Cited by 633
Metadata
- Authors
- Linsel-Nitschke, P., & Tall, A. R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-03-01
- Volume
- 4
- Issue
- 3
- Pages
- 193-205
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1979080082
- Cited by
- 486
- References
- 153
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.